[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neurothrombectomy Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

April 2024 | 191 pages | ID: G87C4061218AEN
APO Research

US$ 4,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.

According to APO Research, The global Neurothrombectomy Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Neurothrombectomy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Neurothrombectomy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Neurothrombectomy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Neurothrombectomy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Neurothrombectomy Devices include Stryker, Medtronic, Penumbra, Phenox and Acandis GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurothrombectomy Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neurothrombectomy Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Neurothrombectomy Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurothrombectomy Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurothrombectomy Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neurothrombectomy Devices sales, projected growth trends, production technology, application and end-user industry.

Neurothrombectomy Devices segment by Company
  • Stryker
  • Medtronic
  • Penumbra
  • Phenox
  • Acandis GmbH
Neurothrombectomy Devices segment by Type
  • Retriever
  • Integrated System
Neurothrombectomy Devices segment by Application
  • Hospitals
  • Clinics
  • Others
Neurothrombectomy Devices segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Study Objectives

1. To analyze and research the global Neurothrombectomy Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurothrombectomy Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurothrombectomy Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Neurothrombectomy Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurothrombectomy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurothrombectomy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurothrombectomy Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurothrombectomy Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurothrombectomy Devices industry.

Chapter 3: Detailed analysis of Neurothrombectomy Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurothrombectomy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurothrombectomy Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
  1.2.1 Global Neurothrombectomy Devices Sales Value (2019-2030)
  1.2.2 Global Neurothrombectomy Devices Sales Volume (2019-2030)
  1.2.3 Global Neurothrombectomy Devices Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives

2 NEUROTHROMBECTOMY DEVICES MARKET DYNAMICS

2.1 Neurothrombectomy Devices Industry Trends
2.2 Neurothrombectomy Devices Industry Drivers
2.3 Neurothrombectomy Devices Industry Opportunities and Challenges
2.4 Neurothrombectomy Devices Industry Restraints

3 NEUROTHROMBECTOMY DEVICES MARKET BY COMPANY

3.1 Global Neurothrombectomy Devices Company Revenue Ranking in 2023
3.2 Global Neurothrombectomy Devices Revenue by Company (2019-2024)
3.3 Global Neurothrombectomy Devices Sales Volume by Company (2019-2024)
3.4 Global Neurothrombectomy Devices Average Price by Company (2019-2024)
3.5 Global Neurothrombectomy Devices Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Neurothrombectomy Devices Company Manufacturing Base & Headquarters
3.7 Global Neurothrombectomy Devices Company, Product Type & Application
3.8 Global Neurothrombectomy Devices Company Commercialization Time
3.9 Market Competitive Analysis
  3.9.1 Global Neurothrombectomy Devices Market CR5 and HHI
  3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
  3.9.3 2023 Neurothrombectomy Devices Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion

4 NEUROTHROMBECTOMY DEVICES MARKET BY TYPE

4.1 Neurothrombectomy Devices Type Introduction
  4.1.1 Retriever
  4.1.2 Integrated System
4.2 Global Neurothrombectomy Devices Sales Volume by Type
  4.2.1 Global Neurothrombectomy Devices Sales Volume by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Neurothrombectomy Devices Sales Volume by Type (2019-2030)
  4.2.3 Global Neurothrombectomy Devices Sales Volume Share by Type (2019-2030)
4.3 Global Neurothrombectomy Devices Sales Value by Type
  4.3.1 Global Neurothrombectomy Devices Sales Value by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Neurothrombectomy Devices Sales Value by Type (2019-2030)
  4.3.3 Global Neurothrombectomy Devices Sales Value Share by Type (2019-2030)

5 NEUROTHROMBECTOMY DEVICES MARKET BY APPLICATION

5.1 Neurothrombectomy Devices Application Introduction
  5.1.1 Hospitals
  5.1.2 Clinics
  5.1.3 Others
5.2 Global Neurothrombectomy Devices Sales Volume by Application
  5.2.1 Global Neurothrombectomy Devices Sales Volume by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Neurothrombectomy Devices Sales Volume by Application (2019-2030)
  5.2.3 Global Neurothrombectomy Devices Sales Volume Share by Application (2019-2030)
5.3 Global Neurothrombectomy Devices Sales Value by Application
  5.3.1 Global Neurothrombectomy Devices Sales Value by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Neurothrombectomy Devices Sales Value by Application (2019-2030)
  5.3.3 Global Neurothrombectomy Devices Sales Value Share by Application (2019-2030)

6 NEUROTHROMBECTOMY DEVICES MARKET BY REGION

6.1 Global Neurothrombectomy Devices Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Neurothrombectomy Devices Sales by Region (2019-2030)
  6.2.1 Global Neurothrombectomy Devices Sales by Region: 2019-2024
  6.2.2 Global Neurothrombectomy Devices Sales by Region (2025-2030)
6.3 Global Neurothrombectomy Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Neurothrombectomy Devices Sales Value by Region (2019-2030)
  6.4.1 Global Neurothrombectomy Devices Sales Value by Region: 2019-2024
  6.4.2 Global Neurothrombectomy Devices Sales Value by Region (2025-2030)
6.5 Global Neurothrombectomy Devices Market Price Analysis by Region (2019-2024)
6.6 North America
  6.6.1 North America Neurothrombectomy Devices Sales Value (2019-2030)
  6.6.2 North America Neurothrombectomy Devices Sales Value Share by Country, 2023 VS 2030
6.7 Europe
  6.7.1 Europe Neurothrombectomy Devices Sales Value (2019-2030)
  6.7.2 Europe Neurothrombectomy Devices Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
  6.8.1 Asia-Pacific Neurothrombectomy Devices Sales Value (2019-2030)
  6.8.2 Asia-Pacific Neurothrombectomy Devices Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
  6.9.1 Latin America Neurothrombectomy Devices Sales Value (2019-2030)
  6.9.2 Latin America Neurothrombectomy Devices Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
  6.10.1 Middle East & Africa Neurothrombectomy Devices Sales Value (2019-2030)
  6.10.2 Middle East & Africa Neurothrombectomy Devices Sales Value Share by Country, 2023 VS 2030

7 NEUROTHROMBECTOMY DEVICES MARKET BY COUNTRY

7.1 Global Neurothrombectomy Devices Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Neurothrombectomy Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Neurothrombectomy Devices Sales by Country (2019-2030)
  7.3.1 Global Neurothrombectomy Devices Sales by Country (2019-2024)
  7.3.2 Global Neurothrombectomy Devices Sales by Country (2025-2030)
7.4 Global Neurothrombectomy Devices Sales Value by Country (2019-2030)
  7.4.1 Global Neurothrombectomy Devices Sales Value by Country (2019-2024)
  7.4.2 Global Neurothrombectomy Devices Sales Value by Country (2025-2030)
7.5 USA
  7.5.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.5.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.5.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.6 Canada
  7.6.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.6.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.6.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.7 Germany
  7.7.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.7.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.7.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.8 France
  7.8.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.8.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.8.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
  7.9.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.9.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.9.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.10 Italy
  7.10.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.10.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.10.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
  7.11.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.11.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.11.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
  7.12.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.12.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.12.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.13 China
  7.13.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.13.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.13.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.14 Japan
  7.14.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.14.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.14.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
  7.15.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.15.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.15.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
  7.16.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.16.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.16.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.17 India
  7.17.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.17.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.17.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.18 Australia
  7.18.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.18.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.18.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
  7.19.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.19.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.19.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
  7.20.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.20.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.20.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
  7.21.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.21.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.21.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
  7.22.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.22.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.22.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030
7.23 UAE
  7.23.1 Global Neurothrombectomy Devices Sales Value Growth Rate (2019-2030)
  7.23.2 Global Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030
  7.23.3 Global Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030

8 COMPANY PROFILES

8.1 Stryker
  8.1.1 Stryker Comapny Information
  8.1.2 Stryker Business Overview
  8.1.3 Stryker Neurothrombectomy Devices Sales, Value and Gross Margin (2019-2024)
  8.1.4 Stryker Neurothrombectomy Devices Product Portfolio
  8.1.5 Stryker Recent Developments
8.2 Medtronic
  8.2.1 Medtronic Comapny Information
  8.2.2 Medtronic Business Overview
  8.2.3 Medtronic Neurothrombectomy Devices Sales, Value and Gross Margin (2019-2024)
  8.2.4 Medtronic Neurothrombectomy Devices Product Portfolio
  8.2.5 Medtronic Recent Developments
8.3 Penumbra
  8.3.1 Penumbra Comapny Information
  8.3.2 Penumbra Business Overview
  8.3.3 Penumbra Neurothrombectomy Devices Sales, Value and Gross Margin (2019-2024)
  8.3.4 Penumbra Neurothrombectomy Devices Product Portfolio
  8.3.5 Penumbra Recent Developments
8.4 Phenox
  8.4.1 Phenox Comapny Information
  8.4.2 Phenox Business Overview
  8.4.3 Phenox Neurothrombectomy Devices Sales, Value and Gross Margin (2019-2024)
  8.4.4 Phenox Neurothrombectomy Devices Product Portfolio
  8.4.5 Phenox Recent Developments
8.5 Acandis GmbH
  8.5.1 Acandis GmbH Comapny Information
  8.5.2 Acandis GmbH Business Overview
  8.5.3 Acandis GmbH Neurothrombectomy Devices Sales, Value and Gross Margin (2019-2024)
  8.5.4 Acandis GmbH Neurothrombectomy Devices Product Portfolio
  8.5.5 Acandis GmbH Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Neurothrombectomy Devices Value Chain Analysis
  9.1.1 Neurothrombectomy Devices Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Neurothrombectomy Devices Sales Mode & Process
9.2 Neurothrombectomy Devices Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Neurothrombectomy Devices Distributors
  9.2.3 Neurothrombectomy Devices Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources

LIST OF TABLES

Table 1. Neurothrombectomy Devices Industry Trends
Table 2. Neurothrombectomy Devices Industry Drivers
Table 3. Neurothrombectomy Devices Industry Opportunities and Challenges
Table 4. Neurothrombectomy Devices Industry Restraints
Table 5. Global Neurothrombectomy Devices Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Neurothrombectomy Devices Revenue Share by Company (2019-2024)
Table 7. Global Neurothrombectomy Devices Sales Volume by Company (K Units) & (2019-2024)
Table 8. Global Neurothrombectomy Devices Sales Volume Share by Company (2019-2024)
Table 9. Global Neurothrombectomy Devices Average Price (USD/Unit) of Company (2019-2024)
Table 10. Global Neurothrombectomy Devices Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Neurothrombectomy Devices Key Company Manufacturing Base & Headquarters
Table 12. Global Neurothrombectomy Devices Company, Product Type & Application
Table 13. Global Neurothrombectomy Devices Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Neurothrombectomy Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Retriever
Table 18. Major Companies of Integrated System
Table 19. Global Neurothrombectomy Devices Sales Volume by Type 2019 VS 2023 VS 2030 (K Units)
Table 20. Global Neurothrombectomy Devices Sales Volume by Type (2019-2024) & (K Units)
Table 21. Global Neurothrombectomy Devices Sales Volume by Type (2025-2030) & (K Units)
Table 22. Global Neurothrombectomy Devices Sales Volume Share by Type (2019-2024)
Table 23. Global Neurothrombectomy Devices Sales Volume Share by Type (2025-2030)
Table 24. Global Neurothrombectomy Devices Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Neurothrombectomy Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Neurothrombectomy Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Neurothrombectomy Devices Sales Value Share by Type (2019-2024)
Table 28. Global Neurothrombectomy Devices Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Hospitals
Table 30. Major Companies of Clinics
Table 31. Major Companies of Others
Table 32. Global Neurothrombectomy Devices Sales Volume by Application 2019 VS 2023 VS 2030 (K Units)
Table 33. Global Neurothrombectomy Devices Sales Volume by Application (2019-2024) & (K Units)
Table 34. Global Neurothrombectomy Devices Sales Volume by Application (2025-2030) & (K Units)
Table 35. Global Neurothrombectomy Devices Sales Volume Share by Application (2019-2024)
Table 36. Global Neurothrombectomy Devices Sales Volume Share by Application (2025-2030)
Table 37. Global Neurothrombectomy Devices Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Neurothrombectomy Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Neurothrombectomy Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Neurothrombectomy Devices Sales Value Share by Application (2019-2024)
Table 41. Global Neurothrombectomy Devices Sales Value Share by Application (2025-2030)
Table 42. Global Neurothrombectomy Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 43. Global Neurothrombectomy Devices Sales by Region (2019-2024) & (K Units)
Table 44. Global Neurothrombectomy Devices Sales Market Share by Region (2019-2024)
Table 45. Global Neurothrombectomy Devices Sales by Region (2025-2030) & (K Units)
Table 46. Global Neurothrombectomy Devices Sales Market Share by Region (2025-2030)
Table 47. Global Neurothrombectomy Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Neurothrombectomy Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Neurothrombectomy Devices Sales Value Share by Region (2019-2024)
Table 50. Global Neurothrombectomy Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Neurothrombectomy Devices Sales Value Share by Region (2025-2030)
Table 52. Global Neurothrombectomy Devices Market Average Price (USD/Unit) by Region (2019-2024)
Table 53. Global Neurothrombectomy Devices Market Average Price (USD/Unit) by Region (2025-2030)
Table 54. Global Neurothrombectomy Devices Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Table 55. Global Neurothrombectomy Devices Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Neurothrombectomy Devices Sales by Country (2019-2024) & (K Units)
Table 57. Global Neurothrombectomy Devices Sales Market Share by Country (2019-2024)
Table 58. Global Neurothrombectomy Devices Sales by Country (2025-2030) & (K Units)
Table 59. Global Neurothrombectomy Devices Sales Market Share by Country (2025-2030)
Table 60. Global Neurothrombectomy Devices Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Neurothrombectomy Devices Sales Value Market Share by Country (2019-2024)
Table 62. Global Neurothrombectomy Devices Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Neurothrombectomy Devices Sales Value Market Share by Country (2025-2030)
Table 64. Stryker Company Information
Table 65. Stryker Business Overview
Table 66. Stryker Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 67. Stryker Neurothrombectomy Devices Product Portfolio
Table 68. Stryker Recent Development
Table 69. Medtronic Company Information
Table 70. Medtronic Business Overview
Table 71. Medtronic Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Medtronic Neurothrombectomy Devices Product Portfolio
Table 73. Medtronic Recent Development
Table 74. Penumbra Company Information
Table 75. Penumbra Business Overview
Table 76. Penumbra Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Penumbra Neurothrombectomy Devices Product Portfolio
Table 78. Penumbra Recent Development
Table 79. Phenox Company Information
Table 80. Phenox Business Overview
Table 81. Phenox Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Phenox Neurothrombectomy Devices Product Portfolio
Table 83. Phenox Recent Development
Table 84. Acandis GmbH Company Information
Table 85. Acandis GmbH Business Overview
Table 86. Acandis GmbH Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Acandis GmbH Neurothrombectomy Devices Product Portfolio
Table 88. Acandis GmbH Recent Development
Table 89. Key Raw Materials
Table 90. Raw Materials Key Suppliers
Table 91. Neurothrombectomy Devices Distributors List
Table 92. Neurothrombectomy Devices Customers List
Table 93. Research Programs/Design for This Report
Table 94. Authors List of This Report
Table 95. Secondary Sources
Table 96. Primary Sources

LIST OF FIGURES

Figure 1. Neurothrombectomy Devices Product Picture
Figure 2. Global Neurothrombectomy Devices Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Neurothrombectomy Devices Sales (2019-2030) & (K Units)
Figure 5. Global Neurothrombectomy Devices Sales Average Price (USD/Unit) & (2019-2030)
Figure 6. Global Neurothrombectomy Devices Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Retriever Picture
Figure 10. Integrated System Picture
Figure 11. Global Neurothrombectomy Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 12. Global Neurothrombectomy Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Neurothrombectomy Devices Sales Volume Share by Type (2019-2030)
Figure 14. Global Neurothrombectomy Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Neurothrombectomy Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Neurothrombectomy Devices Sales Value Share by Type (2019-2030)
Figure 17. Hospitals Picture
Figure 18. Clinics Picture
Figure 19. Others Picture
Figure 20. Global Neurothrombectomy Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 21. Global Neurothrombectomy Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Neurothrombectomy Devices Sales Volume Share by Application (2019-2030)
Figure 23. Global Neurothrombectomy Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Neurothrombectomy Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Neurothrombectomy Devices Sales Value Share by Application (2019-2030)
Figure 26. Global Neurothrombectomy Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 27. Global Neurothrombectomy Devices Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Neurothrombectomy Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Neurothrombectomy Devices Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Neurothrombectomy Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Neurothrombectomy Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Neurothrombectomy Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Neurothrombectomy Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Neurothrombectomy Devices Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Neurothrombectomy Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi Arabia Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 94. UAE Neurothrombectomy Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 95. UAE Neurothrombectomy Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 96. UAE Neurothrombectomy Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 97. Neurothrombectomy Devices Value Chain
Figure 98. Manufacturing Cost Structure
Figure 99. Neurothrombectomy Devices Sales Mode & Process
Figure 100. Direct Comparison with Distribution Share
Figure 101. Distributors Profiles
Figure 102. Years Considered
Figure 103. Research Process
Figure 104. Key Executives Interviewed


More Publications